Cyclopharm Limited announced a private placement of 100,000 common shares at an issue price of AUD 2.18 for the gross proceeds of AUD 218,000 on April 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 AUD | 0.00% | -1.69% | -9.09% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 107M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Limited announced that it expects to receive AUD 0.218 million in funding